Usa Financial Portformulas Corp Amphastar Pharmaceuticals, Inc. Transaction History

Usa Financial Portformulas Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 27, 2023	SELL	$45.51 - $65.0 $53,337 - $76,180	-1,172 Reduced 99.24%	9 $0
Q3 2022 Oct 24, 2022	SELL	$27.56 - $37.75 $36,765 - $50,358	-1,334 Reduced 53.04%	1,181 $33,000
Q2 2022 Aug 15, 2022	SELL	$29.79 - $42.29 $26,811 - $38,061	-900 Reduced 26.35%	2,515 $87,000
Q1 2022 Aug 16, 2022	BUY	$22.96 - $36.45 $78,408 - $124,476	3,415 New	3,415 $123,000

257

33.6M

20.8K

11.6K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.27B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.